CapVest Partners has agreed to purchase a majority stake in German generics manufacturer Stada Arzneimittel, marking one of the largest deals in the healthcare sector this year. Takeover company ...

The World Health Organisation recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...

In the world of high-level programming languages, developers constantly deal with ** [object/struct]** types of highly ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

The Food and Drug Administration sees no difference between brand-name and generic medications for depression. Most psychiatrists readily prescribe generics as effective copies of the original.

DUBLIN--(BUSINESS WIRE)--The "Saudi Arabia Generic Drugs Market Outlook and Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Saudi Arabia Generic Drugs Market is ...

If Java is not working in Windows 11/10, these solutions may help you troubleshoot the issue. Although, due to the lack of NPAPI support, Java applets stopped working in Microsoft Edge, Google Chrome, ...

Last week, Natco Pharma filed six lawsuits in the Delhi High Court against Danish drugmaker Novo Nordisk for its popular anti-obesity drug semaglutide, sold as Wegovy in India. The Hyderabad-based ...

New Delhi: In a move aimed at facilitating faster roll out of generic drugs in the country and easing clinical research of investigational therapies for drugmakers, the Union health ministry is set to ...